Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Vertex

20 innovative breakthroughs that will transform your health

We recognize some of the most staggering, game-changing, life-improving developments of the year.

Fortune

Decoding 9 Analyst Evaluations For Vertex

During the last three months, 9 analysts shared their evaluations of Vertex (NASDAQ:VERX), revealing diverse outlooks from bullish to bearish.

Benzinga

A Glimpse Into The Expert Outlook On Vertex Pharmaceuticals Through 19 Analysts

In the last three months, 19 analysts have published ratings on Vertex Pharmaceuticals (NASDAQ:VRTX), offering a diverse range of perspectives from bullish to bearish.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Is Wall Street Bullish or Bearish on Vertex Pharmaceuticals Stock?

Vertex Pharmaceuticals has outperformed the broader market over the past year, and analysts are moderately optimistic about the stock’s prospects.

Barchart

Five S&P 500 Stocks On This Elite IBD List Near Buy Points

Meta stock and Nvidia peer Broadcom are among among five S&P 500 stocks on IBD Leaderboard that are near buy points.

Investors Business Daily

Stock Market: Three Top Names In Buy Zones, One With Earnings Due

The stock market awaits reports from Home Depot, Disney and Cisco Systems. Cisco, Costco and Vertex are in buy zones.

Investors Business Daily

Dow Jones Futures Rise, Bitcoin Tops $82,000 In Trump Rally; Tesla Spikes Amid Big Price Target

Futures inched higher while bitcoin topped $82,000 as the Donald Trump rally continues. Nvidia, Meta lead five stocks near buy points.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Stock Market Surges To Highs On Trump Election; Fed Cuts Rates, Palantir Soars: Weekly Review

The stock market surged to highs on Donald Trump's election win. A Fed rate cut and a slew of big earnings reports filled out a busy week.

Investors Business Daily

Vertex Flashes A Surprise Buy Point As Non-Opioid Pain Drug Looms

Vertex beat Wall Street's third-quarter expectations, but the real story for Vertex stock is still to come, analysts said Tuesday.

Investors Business Daily

Nasdaq Cuts Losses, But Indexes Stay In The Red; Fortinet Triggers New Buy Point, Palo Alto Networks Approaches Breakout Entry (Live Coverage)

Small caps endured a bigger blow as U.S. consumer prices rose 2.4% in September.

Investors Business Daily

Is Vertex Pharmaceuticals Stock Outperforming the Nasdaq?

Vertex Pharmaceuticals has outperformed the Nasdaq over the past year, and analysts remain moderately bullish about the stock's prospects.

Barchart

Are Wall Street Analysts Bullish on Vertex Pharmaceuticals Stock?

Vertex Pharmaceuticals has outperformed the broader market in 2024 but Wall Street analysts remain cautiously bullish about the stock's potential.

Barchart

Vertex Slumps As Guidance Hike — Featuring The Gene-Editing Launch — Fails To Erase Losses

Vertex stock fell late Thursday after the company reported light sales and wide losses. But the company boosted its outlook for the year.

Investors Business Daily

The British watch brands to know now: from intriguing innovators to heritage revivals

British watch brands are in the ascendant – discover some of the most exciting names and their timepieces

Wallpaper

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Is Vertex Stock Outperforming the S&P 500?

Vertex has outperformed the S&P 500 over the past year, and analysts are moderately bullish on the stock.

Investors Business Daily

Dow Jones Futures Fall As Growth Fears Mount; 7 Stocks Near Buy Points

The stock market was mixed Monday, but once again closed strong. Nvidia jumped while Meta and Spotify are stocks near buy points.

Investors Business Daily

S&P 500 Giants Lead Five Healthy Stocks Near Buy Points

Eli Lilly is in a buy zone, while weight-loss drug rival Novo Nordisk just forged a lower entry.

Investors Business Daily

Dow Jones Futures Fall; Toast Leads 5 New Buys; Robinhood, Arm Are Earnings Movers

The S&P 500 was quiet again, but Toast led several new buys. Robinhood and Arm were big earnings movers late.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Vertex's Pain Drug Could Be Worth Up To $11.4 Billion — Ongoing Debate Sparks Shares

Vertex stock advanced Tuesday as analysts debated the company's pain drug with one saying it could eventually generate $11.4 billion in sales.

Creative Bloq

Vertex 2024 - our best bits and some surprises

We had a blast at Vertex 2024, here are the highlights.

Advnture

Arc’teryx Vertex Alpine GTX approach shoe review: style and performance on above-the-treeline adventures

The close-fitting Arc’teryx Vertex Alpine GTX approach shoe offers reassuring rigidity, protection and grip for battles against gravity

Creative Bloq

Don't miss the chance to get pro tips from ILM concept artist Bimpe Alliu

Improve your portfolio with personalised one-on-one advice.

Investors Business Daily

Alpine Catapults 37% After Vertex Pledges $4.9 Billion To Buy It

Vertex Pharmaceuticals will pay $4.9 billion to acquire Alpine Immune Sciences. Alpine stock rocketed almost 21% on rumors of the deal.

Guitar World

“It’s not the world’s greatest solo, but we spent hours on it”: Session legend Dann Huff recalls recording with Michael Jackson and Shania Twain – and begging Michael Bolton to let him play a solo with a Peavey acoustic

Huff recounts his session contributions during a new in-depth interview – and explains how his heavily-modded ‘64 Strat “cut through the synthesizers of the ‘80s” and put him in great demand

Investors Business Daily

Crispr Stock, A Cathie Wood Holding, Dives For The Fifth Straight Week — Here's Why

Crispr stock is down for the fifth straight week as the top Cathie Wood's holding struggles amid dim expectations for its gene-editing drug.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations